Stocks and Investing
Stocks and Investing
Thu, May 25, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thibault Boutherin Initiated (TEVA) at Hold and Held Target at $10 on, May 25th, 2023
Thibault Boutherin of Morgan Stanley, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $10 on, May 25th, 2023.
Thibault has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 0 agree with Thibault's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Thibault
- Umer Raffat of "Evercore ISI Group" Upgraded from Hold to Buy on, Thursday, May 18th, 2023
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $11 on, Thursday, May 11th, 2023
- Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $14 on, Thursday, February 9th, 2023
Contributing Sources